CD4+ Treg cells in the tumor microenvironment (TME) express high levels of PD-1 (programmed cell death protein 1), suggesting that PD-1 blockade might enhance Treg’s immunosuppressive function. The gene discussed is PDCD1; the disease is neoplasm.